Healthy Extracts (HYEX) Share-based Compensation (2019 - 2025)
Healthy Extracts' (HYEX) quarterly Share-based Compensation came in at $122036.0 in Q4 2025, up 124.56% year-on-year from $54345.0 in Q4 2024, and up 32.2% quarter-over-quarter from $92312.0 in Q3 2025.
Healthy Extracts (HYEX) Share-based Compensation (2019 - 2025) Analysis & Trends
Healthy Extracts' Share-based Compensation history runs 6 years deep, the most recent figure standing at $122036.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 124.56% year-over-year to $122036.0 in Q4 2025; TTM through Dec 2025 was $309500.0, a 2.53% increase from a year earlier, with the FY2025 full-year figure at $309500.0, up 2.53% from the prior year.
- Share-based Compensation improved to $122036.0 in Q4 2025 per HYEX's latest filing, from $92312.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.1 million in Q2 2023 and bottomed at -$434836.0 in Q4 2021.
- The 5-year median for Share-based Compensation is $92312.0 (2025), against an average of $156038.2.
- Across the five-year window, Share-based Compensation tumbled 121.73% in 2022 and surged 726.8% in 2023, its largest moves.
- Year by year, Share-based Compensation stood at -$434836.0 in 2021, then soared by 95.35% to -$20200.0 in 2022, then soared by 1900.59% to $363720.0 in 2023, then slumped by 85.06% to $54345.0 in 2024, then surged by 124.56% to $122036.0 in 2025.
- Per Business Quant, the three latest HYEX Share-based Compensation figures stand at $122036.0 (Q4 2025), $92312.0 (Q3 2025), and $46161.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 122,036.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,036.00 |
| Dec 31, 2025 | 122,036.00 |
| Sep 30, 2025 | 92,312.00 |
| Sep 30, 2025 | 92,312.00 |
| Jun 30, 2025 | 46,161.00 |
| Jun 30, 2025 | 46,161.00 |
| Mar 31, 2025 | 48,991.00 |
| Mar 31, 2025 | 48,991.00 |
| Dec 31, 2024 | 54,345.00 |
| Dec 31, 2024 | 54,345.00 |
| Sep 30, 2024 | 54,345.00 |
| Sep 30, 2024 | 54,345.00 |
| Jun 30, 2024 | 134,854.00 |
| Jun 30, 2024 | 134,854.00 |
| Mar 31, 2024 | 58,314.00 |
| Mar 31, 2024 | 58,314.00 |
| Dec 31, 2023 | 363,720.00 |
| Dec 31, 2023 | 363,720.00 |
| Sep 30, 2023 | 126,614.00 |
| Sep 30, 2023 | 126,614.00 |